Related Experiment Video

Updated: Aug 12, 2026

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Prenatal alcohol exposure and offspring hyperactivity: effects of physostigmine and neostigmine

N W Bond1

  • 1School of Behavioural Sciences, Macquarie University, N.S.W., Australia.

Neurotoxicology and Teratology
|January 1, 1988
PubMed

Insights

Prenatal alcohol exposure in rats leads to hyperactivity in offspring. This exposure delays the development of a key inhibitory system, impacting their activity levels and response to drugs.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Prenatal alcohol exposure (PAE) is a significant risk factor for neurodevelopmental disorders.
  • Understanding the long-term effects of PAE on brain development and behavior is crucial.

Purpose of the Study:

  • To investigate the impact of prenatal alcohol exposure on offspring activity levels.
  • To examine the development and function of the cholinergic system in rats exposed to alcohol in utero.
  • To assess the effects of physostigmine and neostigmine on the activity of offspring with and without PAE.

Main Methods:

  • Rats were administered a liquid ethanol diet during gestation (days 6-19).
  • Control groups received a sucrose diet or standard chow and water.
  • Offspring activity was measured at various ages (10, 16, 22, 28 days).
  • Physostigmine and neostigmine were administered to assess cholinergic system function.

Main Results:

  • Offspring exposed to alcohol prenatally exhibited hyperactivity at 16 and 22 days of age.
  • Physostigmine differentially affected activity based on age and exposure group.
  • At 22 days, physostigmine decreased activity in controls but not in alcohol-exposed pups.
  • Neostigmine administration suggested central origins for scopolamine effects.

Conclusions:

  • Prenatal alcohol exposure delays the maturation of a central cholinergic/inhibitory system in rats.
  • This developmental delay in the cholinergic system correlates with altered activity levels in offspring.
  • The findings highlight the neurodevelopmental consequences of PAE on motor control and neurotransmitter system development.

More Related Videos

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders19:57

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders

Published on: August 5, 2017

Related Concept Videos

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.